Chang, T., Lee, Y., Wu, L., & Chang, C. (2024). Albuminuria-based stratification of end-stage kidney disease progression and mortality with sodium-glucose cotransporter 2 inhibitors (SGLT2i): A retrospective cohort study in type 2 diabetes and chronic kidney disease. Pharmacotherapy, 44(11), 828. https://doi.org/10.1002/phar.4615
Chicago Style (17th ed.) CitationChang, Tien-Jyun, Yen-Chieh Lee, Li-Chiu Wu, and Chia-Hsuin Chang. "Albuminuria-based Stratification of End-stage Kidney Disease Progression and Mortality with Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): A Retrospective Cohort Study in Type 2 Diabetes and Chronic Kidney Disease." Pharmacotherapy 44, no. 11 (2024): 828. https://doi.org/10.1002/phar.4615.
MLA (9th ed.) CitationChang, Tien-Jyun, et al. "Albuminuria-based Stratification of End-stage Kidney Disease Progression and Mortality with Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): A Retrospective Cohort Study in Type 2 Diabetes and Chronic Kidney Disease." Pharmacotherapy, vol. 44, no. 11, 2024, p. 828, https://doi.org/10.1002/phar.4615.